SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

India Glycols, Clariant establish Joint Venture for renewable ethylene oxide derivatives

01 Jul 2021 Evaluate

India Glycols (IGL) and Clariant have completed the creation of their 49-51% joint venture for renewable ethylene oxide (EO) derivatives after receiving all necessary regulatory approvals. The joint venture will operate under the name Clariant IGL Specialty Chemicals.

Originally announced in March 2021, the joint venture combines IGL's renewable bio-ethylene oxide derivatives business, which includes a multipurpose production facility including an alkoxylation plant located in Kashipur, Uttarakhand (India), with Clariant's local Industrial and Consumer Specialties business in India, Sri Lanka, Bangladesh and Nepal. Clariant International will be the sole Clariant shareholder with a 51% stake in the JV. IGL along with its subsidiary will hold a 49% stake in the JV.

The JV's production facilities in India will supply to local and global markets, creating one of the largest Green-focused specialty chemicals (EO Derivative) companies. The combining of production and distribution capacities will make this JV a leader in green ethylene oxide derivatives and become a key supplier of these renewable materials to the rapidly growing consumer care market in India and her neighboring countries. To support the manufacturing in this entity, IGL has agreed to a long-term supply agreement for ethylene oxide made from bio-ethanol and certain utilities. 

India Glycols manufactures Industrial Chemicals such as green technology based bulk, specialty and performance chemicals and natural gums and industrial gases; Ethyl Alcohol (Potable) and nutraceuticals.

India Glycols Share Price

960.05 -13.10 (-1.35%)
24-Apr-2026 15:40 View Price Chart
Peers
Company Name CMP
United Spirits 1390.80
United Breweries 1475.50
Radico Khaitan 3196.15
India Glycols 960.05
Allied Blenders 560.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×